Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Viad Exploring Opportunities To Boost Shareholder Value

RELATED NEWS
Trade VVI now with 

Viad Corp (VVI: Quote) said Friday that its Board of Directors has authorized management to explore and evaluate opportunities to enhance shareholder value, including a potential separation of its Travel & Recreation and Marketing & Events businesses.

The Viad Board previously hired and has been working with J.P. Morgan Securities LLC as its financial advisor to assist in the evaluation process.

The company also said its board has authorized the repurchase of up to an additional one million shares of the company's common stock, from time to time at prevailing market prices.

As of September 30, the company had repurchased about 610,000 shares since September 2010 pursuant to previously announced authorizations by the board, which represents substantially all of the shares available for repurchase under existing announced authorizations.

The company also said that its Amended and Restated Credit Agreement, dated May 18, 2011, was amended, effective as of December 12, 2012, to remove the prior limitation on share repurchases of $10 million in the aggregate per calendar year. The amendment now allows share repurchases unless the Company's leverage ratio, as defined in the Credit Agreement, is greater than 1.50 to 1.00 or a default or an unmatured default, as defined in the Credit Agreement, exists. As of September 30, 2012, the company's leverage ratio was 0.21 to 1.

Register
To receive FREE breaking news email alerts for Viad Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A Thai company has bought iconic U.S. tuna brand Bumble Bee for $1.51 billion dollars. Thai Union Frozen Products Public Company Limited or TUF, the world's largest processor of shelf-stable tuna products snapped up Bumble Bee from private equity firm Lion Capital. Post Synergies, the transaction... Here is a list of interesting stocks to watch on December 19. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed below and many more have been researched already, and... Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.